Scientists at The University of New Mexico have developed a groundbreaking vaccine targeting high cholesterol, a leading cause of heart disease and stroke. The vaccine, aimed at lowering LDL cholesterol levels by targeting the PCSK9 protein, offers a potentially more affordable treatment option compared to current drugs like PCSK9 inhibitors. Join the discussion on how this innovative vaccine could revolutionize cardiovascular care and global health.

Learn more about the cholesterol-lowering vaccine or Bryce Chackerian's lab.

Read the study published in NPJ Vaccines.

Donate to the UNM Big Give from now through 11:59 p.m., February 21.

Learn more about the show on podcast.unm.edu and follow it on ⁠Instagram⁠ and ⁠TikTok.